Phase II trial of Eribulin/S-1 combination therapy for advanced/recurrent breast cancer

被引：0
|
作者：
Iwasa, Tsutomu [1 ]
Komoike, Yoshifumi [7 ]
Tsurutani, Junji [1 ]
Nakagawa, Kazuhiko [1 ]
Mizuno, Yutaka [2 ]
Matsunami, Nobuki [3 ]
Yamamura, Jun [4 ]
Otani, Shoichiro [5 ]
Kojima, Yasuyuki [6 ]
Watanabe, Satomi [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
[2] Yokkaichi Municipal Hosp, Dept Breast Surg, Yokaichi, Japan
[3] Osaka Rosai Hosp, Dept Breast Surg, Sakai, Osaka, Japan
[4] Sakai City Med Ctr, Dept Breast & Endocrine Surg, Sakai, Osaka, Japan
[5] Hiroshima City Hiroshima Citizens Hosp, Dept Breast Surg, Hiroshima, Japan
[6] St Marianna Univ, Sch Med, Dept Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan
[7] Kinki Univ, Fac Med, Dept Breast & Endocrine Surg, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-15-2
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II clinical trial of eribulin in advanced or recurrent cervical cancer (CC).
    Garcia, Jocelyn
    Lin, Yvonne Gail
    Louie, Stan
    Yoo, EunJeong
    Tsao-Wei, Denice D.
    Tierney, Katherine E.
    Brunette, Laurie Leigh
    Matsuo, Koji
    Pham, Huyen Q.
    Yessaian, Annie A.
    Groshen, Susan G.
    Facio, Grace
    Watkins, Kristy
    Roman, Lynda D.
    Muderspach, Laila I.
    Garcia, Agustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase II clinical trial of eribulin (E) in advanced/recurrent cervical cancer
    Garcia, Jocelyn
    Lin, Yvonne Gail
    Louie, Stan
    Fauceglia, Paulette
    Tsao-Wei, Denice D.
    Yoo, EunJeong
    Ciccone, Marcia
    Adams, Crystal
    Brunette, Laurie Leigh
    Matsuo, Koji
    Pham, Huyen Q.
    Yessaian, Annie A.
    Groshen, Susan G.
    Facio, Grace
    Watkins, Kristy
    Muderspach, Laila I.
    Garcia, Agustin A.
    Roman, Lynda D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer
    Yoshida, K
    Hirabayashi, N
    Takiyama, W
    Ninomiya, M
    Takakura, N
    Sakamoto, J
    Nishiyama, M
    Toge, T
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1843 - 1851
  • [24] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [25] Phase II study of S-1 in patients with advanced or recurrent cervical cancer
    Hirai, Y.
    Katsumata, N.
    Kamiura, S.
    Sugiyama, T.
    Kokawa, K.
    Hatae, M.
    Nishimura, R.
    Ochiai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Saito, Kei
    Sasaki, Takashi
    Takahara, Naminatsu
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Mohri, Dai
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 911 - 915
  • [27] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
    Yousuke Nakai
    Hiroyuki Isayama
    Kei Saito
    Takashi Sasaki
    Naminatsu Takahara
    Tsuyoshi Hamada
    Suguru Mizuno
    Koji Miyabayashi
    Keisuke Yamamoto
    Dai Mohri
    Hirofumi Kogure
    Natsuyo Yamamoto
    Kenji Hirano
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 911 - 915
  • [28] Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
    Kawabata, Ryohei
    Fujiwara, Yoshiyuki
    Doki, Yuichiro
    Fujita, Junya
    Tsukahara, Yasuo
    Yamasaki, Makoto
    Miyata, Hiroshi
    Takiguchi, Shuji
    Monden, Morito
    ONCOLOGY, 2007, 72 (3-4) : 219 - 225
  • [29] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Makoto Akaike
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Naoto Yamamoto
    Soichiro Morinaga
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 987 - 992
  • [30] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
12345